methylprednisolone has been researched along with Histoplasmosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Song, D; Wang, J; Wang, Z | 1 |
| Castelli, A; Laurini, L; Massai, L; Romano, C | 1 |
2 other study(ies) available for methylprednisolone and Histoplasmosis
| Article | Year |
|---|---|
Hemophagocytic lymphohistiocytosis secondary to disseminated histoplasmosis in an immunocompetent patient.
Topics: Adolescent; Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Doxorubicin; Etoposide; Histoplasmosis; Humans; Immunocompetence; Lymphohistiocytosis, Hemophagocytic; Male; Mass Spectrometry; Methylprednisolone; Treatment Outcome | 2021 |
Case report. Primary cutaneous histoplasmosis in an immunosuppressed patient.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Rheumatoid; Dermatomycoses; Fluconazole; Follow-Up Studies; Forearm; Hand; Histoplasma; Histoplasmosis; Humans; Immunocompromised Host; Itraconazole; Male; Methylprednisolone; Skin | 2000 |